Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LS9E
|
||||
| Drug Name |
Durvalumab
|
||||
| Synonyms |
Imfinzi
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Indication | Advanced or metastatic urothelial carcinoma [ICD10:C67] | Approved | [889446] | ||
| Company |
Astrazeneca Uk Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Programmed cell deathe?Y? ligand 1 (PD-L1) | Target Info | Modulator | [556264] | |
| KEGG Pathway | Cell adhesion molecules (CAMs) | ||||
| Reactome | PD-1 signaling | ||||
| WikiPathways | Costimulation by the CD28 family | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.